TWi Biotechnology

TWi Biotechnology Overview

  • Founded
  • 2010
Founded
  • Status
  • Public
  • Employees
  • 9
Employees
  • Stock Symbol
  • 6610
Stock Symbol
  • Share Price
  • $0.24
  • (As of Wednesday Closing)

TWi Biotechnology General Information

Description

TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
ROCO
Primary Office
  • 8F, Number 41, Lane 221
  • Gangying Road, Neihu District
  • Taipei, 114-94
  • Taiwan
+886 02 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

TWi Biotechnology Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.24 $0.23 $0.17 - $0.65 $15.9M 67.4M 46.9K -$0.05

TWi Biotechnology Financials Summary

In Thousands,
USD
TTM 31-Dec-2019 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 5,774 5,774 38,848 57,475
Revenue 313 313 856 2,459
EBITDA (3,251) (3,251) (3,457) (2,971)
Net Income (3,609) (3,609) (3,730) (3,436)
Total Assets 14,327 14,327 17,723 9,249
Total Debt 87 87 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

TWi Biotechnology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore TWi Biotechnology‘s full profile, request access.

Request a free trial

TWi Biotechnology Executive Team (2)

Name Title Board Seat Contact Info
Guang-Wei Lu Ph.D Senior Research & Development Deputy General Manager

1 Former Executive

Ready to get started?

Request a free trial